Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate to severe atopic dermatitis after it failed to meet efficacy goals in an ...
The 15-day trial centers on Gayle Emerson, a Pennsylvania woman who claimed that her use of Johnson & Johnson's baby powder ...
London — Thousands of people in the United Kingdom have filed a joint legal claim estimated to be worth more than £1 billion ($1.34 billion) against Johnson & Johnson, accusing the U.S. pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results